Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Orama Labs completes first PYTHIA buyback and burn, marking the official entry of PYTHIA into a deflationary era

Orama Labs completes first PYTHIA buyback and burn, marking the official entry of PYTHIA into a deflationary era

ChaincatcherChaincatcher2025/11/11 06:36
Show original

ChainCatcher reported that DeSci & AI asset issuance protocol Orama Labs today announced the execution of its first burn of governance token $PYTHIA. A total of 215,310 PYTHIA tokens were burned, marking the official launch of its deflationary mechanism and further strengthening the long-term value support of its token economic model.

This burn follows the successful launch of Orama Labs' first ecosystem project, ZENO. According to previously announced Tokenomics, the platform will return 50% of fee income directly to project creators to continuously support the development of ecosystem projects, while the remaining portion will be used to promote value-empowering measures including buyback and burn.

As an issuance protocol in the Solana ecosystem focused on DeSci and AI assets, Orama Labs has demonstrated its commitment to building a sustainable, deflationary token economy through this burn.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks